Ford made the exact announcement that I said 6 months ago that they would make by spring. They are moving to be 100% EV by 2030 and 100% EV and hybrid by 2026. How did I know the exact announcement? Deep research and analysis. I did the work. And now, we are already up double on our Ford investment. We expect much, much more. Think Tesla like returns. Available to members of Sustainable Growth or higher membership.
Compass Diversified Holdings SWOT Report.
Ulta Beauty Inc. has been a leader under top management. Their business is largely recession proof. See our opinion and analysis of the stock (ULTA). Members only. Become a member for only $149 (half price) with a “Sustainable Growth” subscription.
Kroger SWOT Analysis │Open to the Public
A Fundamental Trends custom SWOT Report of a duopoly leader in the booming solar energy space. This company’s stock has already jumped, but we think has a long way to rise.
A Fundamental Trends custom SWOT Report of a leader in the developing global cloud and eCommerce space. This massive opportunity could give you a chance to invest 5-10 years ago with the benefit of hindsight.
A Fundamental Trends custom SWOT Report about a leader at the heart of streaming TV. This company is misunderstood by many and has an exceptional future in monetizing advertising and other entertainment.
A Fundamental Trends custom SWOT Report on a leader in the FinTech explosion. This company can bypass banks or work with them, lends, does P2P, crowd funding, small business, online, crypto…
A Fundamental Trends custom SWOT Report on one of the companies leading the virtual medicine revolution. See the future of healthcare.
A Fundamental Trends custom SWOT Report on one of the companies leading the 4th Industrial Revolution. An AR & IoT leader.
Calix is on our “very short lists” of companies to watch and potentially buy at the right price. Our SWOT analysis provide the essentials for getting to know a company and develop an investment thesis.
AbbVie’s (ABBV) stock has been under pressure for over a year on concerns about Humira’s patent expiration in Europe last year and the loss of protection from competition in the United States beginning in 2023. As a result of these concerns, AbbVie’s stock declined 38% from $123 down to the current price of $76.87. The sharp decline has the stock trading at a bargain valuation.
AbbVie is one of the leading pharma companies in the world. It’s growth however is in question as Humira slowly get biosimilar competition.
Tesla (TSLA) stimulates plenty of debate these days regarding whether the company will achieve long-term success or will succumb to bankruptcy or maybe a combination of both. I will show how Tesla’s valuation improved and how long-term trends are likely to work in Tesla’s favor. On top of this, Elon Musk’s ‘whatever it takes’ mindset provides an additional driver for Tesla to avoid bankruptcy and achieve long-term success for the company and the stock.
Qualcomm is a tech leader that pays a significant dividend. Expansion of 5G and the IoT should drive renewed growth in coming years. Retirement investors may want to consider adding this “new economy” dividend stock to portfolios at the right price.